SCHEMBL23873007

SCHEMBL23873007

c1ccc(Cc2cc(N(c3ccccc3)c3ccccc3)cc(N(c3ccccc3)c3ccccc3)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.52
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
IDH1 O75874 1/20 0.41
TSHR P16473 1/20 0.41
GRM2 Q14416 1/20 0.39
BCL2 P10415 1/20 0.39
BCL2L1 Q07817 1/20 0.39
LTA4H P09960 2/20 0.38
TP53 P04637 1/20 0.37
PTPN1 P18031 2/20 0.37
PTPN2 P17706 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10039126 0.96 ALDH1A1 (0.44) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL26236782 0.87 CALM1 (0.43) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL13136836 0.85 CALM1 (0.50) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL12551590 0.84 CYP2C19 (0.47) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3162196 0.84 CALM1 (0.60) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL23992505 0.84 CALM1 (0.60) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL14018354 0.81 CALM1 (0.55) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL9768685 0.81 CALM1 (0.55) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL10659841 0.81 CALM1 (0.63) CALM1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL12551582 0.81 CYP1A2 (0.40) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11839150-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-05 US disclosed
US-11653561-B2 Organic electroluminescence device and fused polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-16 US disclosed
US-20210305512-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND CONDENSED CYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210305512-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND CONDENSED CYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE ODC1, OCIAD1, PIEZO1 CALM1 3366/4885CYP1A2 1897/4885CYP2D6 2721/4885
US-11653561-B2 Organic electroluminescence device and fused polycyclic compound for organic electroluminescence device PIEZO1, LEF1, ODC1 CALM1 2483/4885CYP1A2 1564/4885CYP2D6 2329/4885
US-11839150-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device ODC1, OCIAD1, PIEZO1 CALM1 3366/4885CYP1A2 1897/4885CYP2D6 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.